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O
ne of the key priorities for staff when dealing 
with intravenous (IV) drugs is to ensure 
the right dose is administered (Grissinger, 
2010). Under-dosing can result in therapy 
failure in general (Roseau et al, 2016) and, 
for antibiotics, can lead to a risk of the emergence of resistant 
organisms (Fish and Ohlinger, 2006). Under-dosing can arise 
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ABSTRACT
Background: intravenous (IV) drugs are administered widely and under-dosing 
can result in therapy failure. The aim of this study was to quantify frequency, 
volume and dose of drug discarded within administration sets in the clinical 
setting. Methods: residual volume for 24 different administration sets was 
measured under controlled conditions in a laboratory. Clinical assessment of 
current practice regarding post-infusion flushing occurred in 6 departments 
of one teaching hospital in the UK over 7 days. Details of drug last infused, 
(concentration, diluent and volume) and type and brand of administration set 
were collected. Results: 74% of administration sets were not flushed. Non-
flushing exceeded 90% and 61% for gravity and pump infusions respectively 
(p<0.001) in all areas excluding oncology. Oncology was the only area where 
flushing was standard practice for all infusions (p<0.001). Mean residual 
volume of the administration sets was 13.1 ml and 16.7 ml for gravity and 
pump sets respectively. Antibiotics were commonly infused and up to 21% of 
antibiotic dose was frequently discarded. Conclusions: the findings suggest 
disposal of substantial volumes of drugs occurs frequently in general hospital 
areas. Without clear national and local policies this unrecognised under-
dosing will continue. 
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due to errors in: calculation, transcription, or preparation of the 
drug (Patient Safety Observatory, 2007). However, a less widely 
known means of under-dosing arises when the administration 
system itself fails to administer all of the prescribed drug 
(Plagge, 2010).  
IV drugs can be administered via either a bolus or an 
infusion (gravity or pump). For a bolus, the standard and 
recommended practice is to flush the cannula after the drug 
has been administered (Infusion Nurses Society, 2006). However, 
following intermittent infusion via an administration set, no such 
flushing recommendation exists—even though the discarded 
set includes residual drug volume. Although residual volume 
has been recognised in some studies, these have involved 
questionnaires and small-scale studies of clinical practice (Plagge, 
2010).  Furthermore, there is nothing in the literature published 
within the last 8 years or relating to practice in the UK.  The 
significant proportion of patients who have an IV cannula and 
require IV drugs merits this issue being quantified and addressed 
by relevant health professionals.  
The authors set out to quantify the problem in terms of 
frequency of drug discarded in the administration set in a 
purposeful sample of clinical areas in one teaching hospital 
and measure the potential volume of drug discarded in different 
administration sets.
Method
This single-site study took place in a large teaching hospital 
in the UK. Six clinical areas with high IV infusion use were 
identified: one oncology day ward, two surgical wards, a cardiac 
intensive care unit, a cardiac high-dependency unit (HDU) 
and an emergency admissions unit. This purposeful sample 
represents a cross-section of clinical areas with diverse IV infusion 
requirements.  Data were collected over 7 consecutive days.
The number of 50 ml and 100 ml bags of saline and glucose 
were counted on each ward/department, demonstrating base 
line availability of potential ‘flush’ bags.
For 7 days, healthcare workers (HCWs) were asked to discard 
all administration sets, along with the attached bag/bottle, 
into a study container rather than the clinical waste container 
(excluding the oncology day ward). No other changes were 
made to the HCWs’ normal practice.
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The study container was emptied daily by the research 
team and the following details for each administration set were 
recorded: 
 ■ Type of set (pump or gravity) 
 ■ Set brand 
 ■ Drug 
 ■ Concentration (%, mg/ml, µg/ml or mmol) 
 ■ Diluent 
 ■ Volume of bag/bottle attached.  
The presence of a 50/100 ml bag of saline or glucose attached 
to the administration set was defined as use of a flush.  
In the oncology day ward, to prevent exposure to 
chemotherapeutic agents and prevent contaminated 
administration sets being discarded outside of trust protocol, 
practice was observed (without the HCWs changing any 
procedures). The same information was recorded via observation.
Inclusions and exclusions were as follows:
 ■ Included: pump and gravity administration sets used for 
intermittent infusion of drugs
 ■ Excluded: any other administration sets, hydration infusions 
(≥500 ml), e.g. glucose, Hartmann’s solution, isotopes, sodium 
chloride and sodium chloride with additives (magnesium and 
potassium chloride or sodium bicarbonate) and continuous 
infusions e.g. insulin.
As practice was observed in the oncology day ward, 
hydration solutions from this area were included as flushes 
because hydration fluids were used to flush between each 
chemotherapeutic agent given and after the final dose before 
disposal of the administration set. 
The medications infused were grouped according to the 
Anatomical Therapeutic Chemical (ATC) classification into 
drug classifications based on the World Health Organization 
(WHO) system. Drugs were grouped according to ATC level 2. 
To quantify discarded volume in administration sets, the 
maximum potential residual volume was measured for a range 
of gravity and pump administration sets available for purchase 
by hospitals in the UK.  The administration sets identified in 
the clinical study were included. Five unused administration 
sets of each brand were filled with saline, then disconnected 
from the saline bottle and the fluid was run off until the drip 
chamber was empty, but the tubing below was full and the 
clamp was applied.  The volume remaining in the tubing was 
measured (from the bottom of the drip chamber to the Luer 
attachment) by opening the clamp and running the remaining 
fluid into a 10 ml measuring cylinder. This maximum residual 
volume was used in data analysis to represent volume discarded 
in the administration sets in clinical practice.
Data were analysed descriptively: volume of IV drug bag/
bottle, calculated residual volume of IV drug in administration 
set, frequency of administration sets flushed and percentage of 
fluid not infused. Volumes of IV drug in bottle/bag and residual 
volume were not normally distributed and the average was 
expressed as median. 
Data were analysed overall and by combined specialty, i.e. 
surgical, oncology day ward, medical critical care and high-
dependency unit and the emergency assessment unit and by 
administration set type (pump or gravity). 
Data were analysed using SPSS version 24. Data distribution 
was assessed using the Kolmogorov-Smirnov test and then 
used mean/median as appropriate. Chi-squared analysis was 
performed for nominal data with P <0.05 as significant.
This was a non-interventional observational feasibility 
study, involving no patient-identifiable markers, and was 
approved as a service evaluation by the research and 
development department of the study site.  
Results
Data were collected from 411 administration sets and combined 
by specialty; 130 sets were excluded (124 hydration solutions, 
5 continuous infusions, 1 epidural set).  The remaining 281 sets 
were included for analysis.
None of the wards had 50 ml sodium chloride or glucose 
present.  All wards had 100 ml sodium chloride present and 
all bar one of the surgical wards had 100 ml glucose available 
for use as a flush.
 Table 1 illustrates the number of administration sets that 
were flushed or not by specialty and category (pump (n=106) 
or gravity (n=175)). Overall 209/281 administration sets were 
not flushed (74%) (Table 1). Apart from the oncology day 
ward, non-flushing exceeded 90% in gravity infusions and 
61% in pump infusions (p<0.001) in all other departments; 
16/17 (94%) pump administration sets that were flushed were 
burette administration sets. Of all administration sets used 
by the oncology day ward, 100% were flushed (p<0.001); all 
were pump administration sets. 
Table 2 demonstrates the range of drugs administered by 
ATC 2 classification, detailing volume, associated residual 
volumes and calculated percent of drug discarded. Analgesics 
(90/281; 32%) and antibiotics (85/281; 30%) were the most 
common drugs administered, none of these were flushed.  The 
next most common drug administered were blood substitutes 
and perfusion solutions (81/281; 29%) of which 72 were flush 
solutions of the infusions, the remaining 9 were unflushed drugs. 
Twenty-four brands of gravity and 13 brands of pump 
administration sets were measured separately for maximum 
residual volume. The mean residual volume was 13.1 ml 
(SD 2.98 ml, range 10.4-20.6 ml) for gravity administration 
sets and 16.7 ml (SD 3.33 ml, range 11.0-21.8 ml) for pump 
administration sets. In the clinical study, 242/281 administration 
sets were identifiable by brand. The maximum residual volume 
was 11.5 ml for gravity and ranged from 16.2 ml to 21.8 ml, with 
a median of 20.8 ml for pump administration sets. Table 2 shows 
the residual volume and calculated percentage of active drug 
discarded in the administration set. Up to 21% of last administered 
drug was calculated as discarded with the administration set.  
Up to 21% of the antibiotic dose was calculated as discarded 
in the administration sets (range 5-21%).  The majority, 57/85 
(67%), of antibiotics were diluted in 100 ml of saline, 17/85 
(20%) and 11/85 (13%) were diluted in 200 ml and 250 ml of 
saline respectively. Median volume of antibiotics was 100 ml. 
Table 3 demonstrates the breakdown by drug name for the two 
most common ATC 2 categories, analgesics and antibiotics, 
and the calculated discarded amount of drug. Paracetamol was 
consistently underdosed by 12% of the prescribed dose.  
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The most common antibacterial used was metronidazole, 
this was underdosed on 30 occasions with up to 21% of the 
drug being discarded within the administration sets. Here 
the median dose of metronidazole was 0.5 g and 62 mg was 
calculated as discarded per dose.  With 6-hourly doses, after 
2 days the equivalent of nearly one full dose (488 mg) will have 
been discarded as residual volume (Joint National Formulary, 
Committee, 2018a). 
Ciprofloxacin was recorded on 18 occasions, with up to 12% 
of the dose calculated as discarded in the administration set.  The 
median dose of ciprofloxacin given here was 380  mg per dose 
and 27 mg per dose was calculated as discarded.  When given 
in 8-hourly intervals (Joint National Formulary Committee, 
2018b), in a 4-day course, the equivalent of one dose will have 
been discarded as residual volume by the end of the course. 
Table 2. Details of the last fluid administered through set as Anatomical Therapeutic Chemical level 2 category, detailing volume, 
calculated residual volume and calculated percent of drug discarded (n=281)
World Health Organization Anatomical 
Therapeutic Chemical level 2 
classifications
n (%) Vol bag/bottle* 
(ml) (range)
Residual volume† (ml) 
(range)
% of drug discarded 
(range)*
Others 3 (1.1) 500 (500–1000) 19 3.8 (1.9–3.8)
Analgesics 90 (32.0) 100 11.5 11.5 
Antibiotics for systemic use 85 (30.3) 100 (100–250) 11.5 (11.5–20.8) 11.5 (4.6–20.8)
Antiepileptics 1 (0.4) 100 20.8 20.8
Anti-inflammatories and anti-rheumatics 1 (0.4) 100 11.5 11.5
Anitmycotics for systemic use 3 (1.1) 100 11.5 11.5
Antithrombotic agents 1 (0.4) 250 20.8 8.32
Antivirals 1 (0.4) 250 11.5 4.6
Blood substitutes and perfusion solution 81 (28.8) 250 (100–1000) 20.8 (11.5–21.8) 2.2 (1.15–20.8)
Drugs for acid-related disorders 12 (4.3) 100 20.8 (11.5–20.8) 20.8 (11.5–20.8)
Vitamins 3 (1.1) 100 11.5 11.5
*Expressed as median. † Residual volume of administration set as measured separately in the lab
Discussion
This study has demonstrated that while small (100 ml) bags of 
fluids are present in ward areas, they are not commonly used to 
flush intermittent IV infusions outside of the oncology day ward. 
The majority of administration sets were not flushed and the 
residual volume of active drug is commonly discarded, resulting 
in a frequent under-recognised under-dosing via IV infusions.
The authors observed that flushing varies by department 
with the oncology day ward flushing all administration sets. The 
local hospital’s anticancer medicine policy addresses flushing 
administration sets in the statement ‘a flush of prescribed compatible 
solution should be administered between each medication and 
on completion of the patient’s regimen’.  However, general trust 
polices do not discuss flushing after other intermittent infusions 
but rather refer the reader to the Royal Marsden Manual of Clinical 
Table 1. The number of administration sets flushed or not by type of administration set and by specialty area
Overall Gravity Pump
Speciality 
area
Number of 
sets
n
Flushed
n (%)
Not flushed
n (%)
Number of 
sets
 n (%)
Flushed
n (%)
Not flushed 
n (%)
Number of 
sets
n (%)
Flushed n 
(%)
Not flushed 
n (%)
Surgical 118 1 
(0.8)
117 
(99.2)
112
(94.9)
1
(0.9)
111
(99.1)
6
(5.1)
0
(0.0)
6
(100.0)
Oncology day 
ward
51 51  
(100)
0
(0)
0
(0)
n/a n/a 51 
(100)
51
(100)
0 
(0.0)
Medical 
critical care 
and HDU
84 17 
(20.2)
67 
(79.8)
42 
(50.0)
1 
(2.4)
41
(97.6)
42 
(50.0)
16
(38.1)
26
(61.9)
Emergency 
admission 
unit
28 3 
(10.7)
25
(89.3)
21
(62.3)
2
(9.5)
19 
(90.5)
7 
(37.7)
1  
(14.3)
6
(85.7)
Overall 281 72
(25.6)
209 
(74.4)
175
(62.3)
4 
(0.3)
171 
(97.7)
106
(37.7)
68
(64.2)
38 
(35.8)
HDU: High-dependency unit
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Nursing Procedures (Dougherty and Lister, 2015). These national 
guidelines also omit the specific need to flush sets to ensure the 
full dose of drug is given.  There is a side note in the national 
guidelines where a flush mini-bag may be considered in line with 
cost implications and risk to patient on restricted fluid intake, but 
there was no discussion of the benefit of total dosing (Dougherty 
and Lister, 2015). A lack of clear local and national guidelines 
appear to be reflected in practice here by the lack of conscious 
thought given to flushing the administration sets, resulting in the 
majority of intermittent infusions not being flushed.  
This study was unable to measure residual drug levels if a 
continuous infusion followed an intermittent drug infusion 
using the same administration set. This possibly led to some 
overestimation of underinfusion.  Also, residual volumes were 
calculated rather than individually measured in the clinical 
setting, which limits the accuracy of the data; however, this 
process enabled a larger number of administration sets to be 
included in the study across a wide variety of wards within the 
site, thus reducing any measurement bias.
Almost one third of the administration sets had antibiotics 
attached on disposal, with up to 21% of the prescribed dose 
being calculated as disposed of within the set. Dosing and efficacy 
of antibiotics remain under discussion (Deryke and Alexander, 
2009; Roberts et al, 2011).  The authors have demonstrated 
that the equivalent volume of one full dose of antibiotic could 
frequently be discarded through a course of treatment due to 
discarding residual volume within the administration set, which 
may affect clinical outcomes. 
Some 30% of the administration sets had antibiotics 
attached—this is in line with national figures where 34.3% 
of patients within the NHS are on antimicrobials (Hopkins 
et al, 2011). Although this study did not look at the impact of 
under-dosing of antibiotics, there are several implications that 
may benefit from further investigation. Patients with reduced 
renal clearance are often given lower doses of antibiotics to 
prevent toxicity; however, these patients can be receiving sub-
therapeutic levels of antibiotics during continuous haemodialysis 
(Wilson and Berns, 2012) requiring extra doses of antibiotic. 
Obese patients are another population where under-dosing 
may occur if dose adjustments are not implemented.  A recent 
review of literature concluded that 23/34 (68%) of antibiotics 
were recommended for obesity-specific dosing (Meng et al, 
2017). These problems may be further unknowingly amplified 
by the disposal of a residual volume of antibiotic within the 
administration set.
A small-scale study by Plagge et al (2010) demonstrated that 
‘dead space’  (residual volume) of administration sets and bottles 
can result in up to 32% of 50 ml infusions  being discarded 
and up to 20% of 100 ml infusions being discarded. Plagge et 
al (2010) recommend a minimum of 100 ml should be used 
and the infusion should be stopped when the drip chamber is 
empty. However,  in the present study the authors observed that 
infusion volumes of at least 100 ml were commonly used and 
yet a considerable volume is disposed of. The authors believe 
that flushing the administration set would be a more beneficial 
means of overcoming these issues.
Table 3. Drug details for the two most common Anatomical Therapeutic Chemical level 2 categories (ATC 2), detailing calculated residual volume, 
prescribed dose, total does, calculated dose and percent discarded.
ATC2 category Drug name n Residual 
volume (ml) 
(range)*
Dose prescribed 
mg/ml (range)*
Total dose 
prescribed 
(g) (range)*
Dose discarded 
(mg) (range)*
% of total dose 
discarded 
(range)*
Analgesics Paracetamol 90 11.5 10.0 1.0 115.0 11.5
Antibacterials for 
systemic use
Ceftriaxone 2 11.5 15
(10.0–20.0)
1.5
(1.0–2.0)
172
(115.0–230.0)
11.5
Ciprofloxacin 18 11.5 
(11.5–20.8)
2.0 0.4
(0.20–0.40)
23.0 
(23.0–41.6)
5.75
5.8–11.5)
Clarithromycin 6 20.8
(11.5–20.8)
2.0 0.5 41.6
(23.0–41.6)
8.3
(4.8–8.4)
Co-amoxiclav 4 11.5 11.5 1.2 138.0 11.5
Levofloxacin 2 15.25
(11.5–19.0)
5.0 0.5 76.25
(57.5–95.0)
15.3
(11.5–19.0)
Meropenem 3 11.5 10.0 1.0 115.0 11.5
Metronidazole 30 11.8
(115–20.8)
5.0 0.5 57.5
(57.5–104.0)
11.5
(11.5–20.8)
Tazocin 6 11.5 45.0 4.5 517.5 11.5
Teicoplanin 4 16.2
(11.5–20.8)
5.5
(4.0–6.0)
0.6
(0.4–0.6)
96.9
(48.0–126.0)
16.2
(11.5–20.8)
Temocillin 7 11.5
(11.5–20.8)
10.0
(4.0–10.0)
1.0 115.0
(83.2–115.0)
11.5
(8.32–11.5)
Vancomycin 3 20.8 4.0
(3.0–4.0)
1.0
(0.75–1.0)
83.2
(62.4–83.2)
8.32
*Expressed as median
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The work here demonstrates that disposal of residual volume 
in administration sets is potentially an under-appreciated and 
unrecognised issue outside of oncology departments and 
highlights the need for further work and national guidance to 
prevent frequent under-dosing. BJN
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